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Coordinated nuclease activities counteract Ku at
single-ended DNA double-strand breaks
Pauline Chanut1,2,*, Se´bastien Britton1,2,3,*, Julia Coates3, Stephen P. Jackson3,4 & Patrick Calsou1,2
Repair of single-ended DNA double-strand breaks (seDSBs) by homologous recombination
(HR) requires the generation of a 30 single-strand DNA overhang by exonuclease activities in
a process called DNA resection. However, it is anticipated that the highly abundant DNA
end-binding protein Ku sequesters seDSBs and shields them from exonuclease activities.
Despite pioneering works in yeast, it is unclear how mammalian cells counteract Ku at
seDSBs to allow HR to proceed. Here we show that in human cells, ATM-dependent
phosphorylation of CtIP and the epistatic and coordinated actions of MRE11 and CtIP nuclease
activities are required to limit the stable loading of Ku on seDSBs. We also provide evidence
for a hitherto unsuspected additional mechanism that contributes to prevent Ku accumulation
at seDSBs, acting downstream of MRE11 endonuclease activity and in parallel with MRE11
exonuclease activity. Finally, we show that Ku persistence at seDSBs compromises Rad51
focus assembly but not DNA resection.
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E
ven a single DNA double-strand break (DSB) is a major
threat to genome integrity, since it creates two new
uncapped chromosomal DNA ends. In the absence of
DNA repair, a DSB can lead to loss of a chromosome or
chromosomal fragment and eventually cell death, while if
inaccurately repaired, it can promote mutations or large DNA
rearrangements such as translocations that can contribute to cell
transformation1. As part of genome maintenance mechanisms,
two main pathways have evolved to repair DSBs in human cells:
non-homologous end joining (NHEJ) and homologous
recombination (HR)2. NHEJ comprises direct ligation of the
DSB ends3 and is initiated by the DNA termini being recognized
by the Ku heterodimer, a highly abundant nuclear protein with
strong afﬁnity for a double-stranded DNA end that is threaded
into its cavity4. Ku bound at a DNA end then recruits the protein
PAXX (refs 5,6) plus the catalytic subunit of the DNA-dependent
protein kinase (DNA-PKcs)7. The complex of Ku and DNA-PKcs
at the DNA end forms the DNA-PK, a serine/threonine kinase
able to phosphorylate various substrates and which regulates the
DNA-end processing by several enzymes before ﬁnal DSB ligation
by the DNA Ligase IV-XRCC4-Cernunnos/XLF complex.
Although several factors such as nuclear architecture,
chromatin and transcriptional context inﬂuence repair-pathway
choice, NHEJ has the capacity to repair any DSB, providing that it
comprises two DNA ends8–10. By contrast, end joining is not
available as a mechanism of repair at single-ended DSBs
(seDSBs), owing to the lack of another DNA end to be ligated
to and therefore, seDSBs are preferentially repaired by HR.
seDSBs can be generated during replication by the collision of
progressing replication forks with various DNA lesions11. Repair
by HR requires a homology template, most often the sister
chromatid, thus helping to explain, why HR is restricted to S and
G2 phases of the cell cycle. HR is initiated by DNA resection: the
exonucleolytic processing of the 50-end of the break to generate a
free 30-single-stranded overhang that is stabilized by it being
coated with replication protein A, a heterotrimeric complex of
RPA70, RPA32 and RPA14 (ref. 2). Notably, free double-stranded
DNA ends in human cells are known to be rapidly bound by Ku,
owing to its high abundance and afﬁnity for DNA termini. In
addition to promoting NHEJ, Ku also shields DNA ends from
exonucleases12–15.
In the unicellular organisms Saccharomyces cerevisiae and
Schizosaccharomyces pombe, the proteins scSae2 and spCtp1
(homologues of the human CtIP protein) together with the
MRE11–RAD50–Xrs2/NBS1 complex initiate DNA resection at
DSB ends through MRE11 endonuclease activity creating an
adjacent DNA nick that is then processed in the 50–30 and 30–50
directions by EXO1-DNA2 and MRE11 exonuclease activities,
respectively16,17. The discovery of MRE11 endo- and exonuclease
inhibitors has recently supported the existence of a similar
mechanism in higher organisms18,19. This mode of ‘bi-directional
resection’ thus helps explain how resection can be initiated in the
presence of Ku, but still leaves the issue of how Ku is ﬁnally
removed from DNA ends to allow HR to proceed. A role for
MRE11 endonuclease activity in the process of Ku release has
been demonstrated in yeast but remains to be tested in
mammalian cells12,20–22. In addition, while parallels between
this mechanism and Spo11 removal from meiotic DSBs have led
to the proposal that eviction of Ku from the DNA end is
performed by MRE11 exonuclease activity ‘pushing’ it away16,
this idea remains to be experimentally tested both in yeast and in
human cells.
Here, by using our recently published method to monitor Ku
accumulation at DSBs23, we show that Ku indeed recognizes
seDSBs in human cells. We also establish that ATM-dependent
phosphorylation of CtIP plus MRE11 endonuclease activity
counteract Ku accumulation at seDSBs. Furthermore, we show
that downstream of MRE11 endonuclease activity, the epistatic
action of MRE11 exonuclease activity and the recently discovered
CtIP ﬂap endonuclease activity24,25 are required to antagonize
Ku, and also for efﬁcient RAD51 loading at seDSBs. Our work
also provides evidence for a hitherto unsuspected mechanism
operating in parallel to MRE11 exonuclease and CtIP ﬂap-
endonuclease activities to counteract Ku persisting at seDSBs.
We propose that MRE11 endonuclease and exonuclease activities
process the DNA ﬂanking Ku, and therefore prime Ku for release
by CtIP 50-ﬂap endonuclease activity. We anticipate that
‘attacking DNA ends from the ﬂanks’ through the coordinated
action of CtIP and MRE11 nuclease activities is a general
mechanism to repair complex DNA lesions congested with
proteins or bulky DNA adducts.
Results
Ku transiently binds to seDSBs. To decipher the mechanisms
regulating Ku binding to and persisting at seDSBs in human cells,
we used the topoisomerase I (TopoI) inhibitor and anticancer
agent camptothecin (CPT). By stabilizing covalent complexes of
TopoI with DNA, CPT promotes the generation of seDSBs
associated with replication forks (Supplementary Fig. 1)26,27.
In agreement with previous ﬁndings28, we observed by
immunoblotting that CPT treatment induced phosphorylation
of RPA32 on Ser-4/Ser-8 (P-RPAS4/S8) in human U2OS cells in a
manner that was abrogated when cells were co-treated with either
the speciﬁc DNA-PK inhibitor NU7441 (DNA-PKi)29 or with the
DNA-replication inhibitor aphidicolin (Fig. 1a, note that
phosphorylated KAP-1, an ATM target, is still generated in the
presence of DNA-PK inhibitor, indicating that DNA-PK
inhibition does not affect DSB induction per se). Because
DNA-PK activity requires Ku binding to DSBs, these ﬁndings
implied that an active DNA-PK complex, composed of the
Ku70-Ku80 dimer and DNA-PKcs, assembles on and is activated
by seDSBs generated by CPT. By using high-resolution imaging,
we examined individual seDSBs marked by resection-dependent
RPA70 foci and therefore directed towards HR-repair. This
revealed that formation of RPA70 foci was accompanied by
phosphorylation of S4/S8 RPA32 (P-RPAS4/S8) after CPT
treatment (Fig. 1b), supporting the idea that seDSBs are initially
recognized by Ku. In agreement with this, inclusion of DNA-PK
inhibitor leads to a global decrease of P-RPAS4/S8 foci number
and intensity (Fig. 1b–d). Importantly, DNA-PK inhibition had
no signiﬁcant effect on RPA70 foci formation in the same cells,
indicating that single-strand DNA (ssDNA) production is
essentially unaffected by DNA-PK inhibition (Fig. 1c).
To establish whether S4/S8 RPA32 phosphorylation is indeed a
read-out of Ku binding to DNA ends, we replaced endogenous
Ku70 by wild-type Ku70 or by the Mut6E mutant of Ku70, which
has been shown to be unable to interact with DNA ends23
(Fig. 1e). Notably, compared with the wild-type control, replacing
of Ku70 by the Mut6E mutant reduced the number and intensity
of P-RPAS4/S8 foci without signiﬁcantly reducing RPA70 foci
formation in the same cells, indicating that DNA resection is
largely unaffected by the inability of Ku to bind DNA (Fig. 1f–h).
Together, these data established that Ku binds to
seDSBs generated by CPT treatment, promoting the assembly
of a functional DNA-PK complex that mediates RPA32
phosphorylation on S4/S8 (Fig. 1i). Next, we assessed whether
Ku persists long enough on seDSBs to allow detection of Ku foci
by high-resolution ﬂuorescence microscopy23. As published
previously23, we observed accumulation of Ku (B250 Ku80 foci
per nucleus; see ref. 23 for quantiﬁcation) at sites of DNA damage
caused by ionizing radiation but not at seDSBs induced by CPT
(Fig. 1j). Collectively, these data suggested that Ku and DNA-
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Figure 1 | RPA32 S4/S8 phosphorylation is a mark of transient Ku association with seDSBs. (a) Immunoblotting of extracts from U2OS cells pre-treated
with the replication inhibitor aphidicolin (APH) or with DNA-PK inhibitor (DNA-PKi), respectively, before being CPT treated. (b) Representative
micrographs of P-RPAS4/S8 and RPA70 foci detected by immunoﬂuorescence in U2OS cells pre-treated with dimethylsulfoxide (DMSO) or DNA-PKi
before being treated with CPT. After treatment, cells were pre-extracted with CSKþ R (see Methods section) before ﬁxation and immunodetection.
(c) Quantiﬁcation of RPA70 and P-RPAS4/S8 foci number per cell. Cells were treated and processed as in b, and foci quantiﬁed as described in Methods.
(d) Graph representing the distribution of individual P-RPAS4/S8 focus intensity. Cells were treated and processed as in b. 6,684 and 8,462 foci were
analysed for the CPTand CPTþDNA-PKi conditions, respectively. (e) Immunoblotting of extracts from U2OS T-REx cells stably transfected with control or
siRNA-resistant wild-type (WT) or Mut6E GFP-FLAG-Ku70, and transfected with the indicated siRNA. (f) Representative micrographs of P-RPAS4/S8 and
RPA70 foci detected by immunoﬂuorescence in U2OS T-REx transfected as in e and treated with CPT. After treatment, cells were pre-extracted with
CSKþ R before ﬁxation and immunodetection. (g) Quantiﬁcation of RPA70 and P-RPAS4/S8 foci number per cell. Cells were treated and processed as in f
and foci quantiﬁed as described in Methods. (h) Graph representing the distribution of individual P-RPAS4/S8 foci intensity in U2OS T-REx cells treated
and processed as in f. 9,970 and 19,995 foci were analysed for the Ku70-WTand Ku70-Mut6E conditions, respectively. (i) Model depicting the proposed
structure transiently forming at seDSB induced by CPT. (j) U2OS cells were treated with ionizing radiation (IR) or CPT before being pre-extracted with
CSKþ R and processed for immunodetection of Ku80 and the replication marker proliferating cell nuclear antigen (PCNA). White scale bars represent
10mm; insets represent  3 magniﬁcation. Error bars are s.d. Signiﬁcant differences between speciﬁed pairs of conditions, as judged by t-test, are
highlighted by stars (*Po0.05). NS, non-signiﬁcant difference.
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PKcs load transiently on seDSBs as reported by DNA-PK-
dependent phosphorylation of RPA32 but that activities prevent
stable Ku binding to these DNA ends repaired by HR.
CtIP prevents Ku accumulation at seDSBs. Since a role for CtIP
homologues scSae2 and spCtp1 in removing Ku from DSBs
has been demonstrated in yeast12,20–22, we next used short-
interfering RNA (siRNA) to deplete CtIP from human cells
(Fig. 2a). As described previously29,30, CtIP depletion strongly
impaired DNA resection as detected by a ﬂow cytometry-based
assay (Supplementary Fig. 2a,b)30 without affecting the amount of
DSB induced by CPT as revealed by quantitative analysis of
the DSB marker phosphorylated histone H2AX (gH2AX,
Supplementary Fig. 2c). Strikingly, CtIP depletion also allowed
accumulation of Ku foci in replicating cells treated with CPT
(see Fig. 2b, right panel, and quantiﬁcation, Fig. 2c). These
ﬁndings thus supported there being a critical role for human CtIP
in counteracting the accumulation of Ku on seDSBs, as has been
reported in yeast for scSae2 and spCtp1 (refs 12,20–22).
Importantly, we found that the sensitization to cell killing by
CPT that is produced by CtIP depletion could be partly rescued
by inhibition of DNA-PK (Fig. 2d), suggesting that toxic repair
events mediated by NHEJ underlie this sensitization. Under these
conditions, DNA-PK inhibition alone had no signiﬁcant impact
on survival of cells transfected with control siRNA, consistent
with CPT inducing DNA ends that are normally not repaired by
NHEJ but by HR.
ATM phosphorylates CtIP to prevent Ku persistence at seDSBs.
In agreement with our previous ﬁndings23 and through the use of
the speciﬁc ATM inhibitor KU55933 (ref. 31), we found that
ATM kinase activity also counteracts Ku at seDSBs, although to a
lesser extent than CtIP depletion (Fig. 2c). Importantly, since
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Figure 2 | CtIP and ATM-dependent CtIP phosphorylations are required to antagonize Ku at seDSBs. (a) Immunoblotting of extracts from U2OS cells
transfected with the indicated siRNA. (b) Representative micrographs of Ku foci visualized by immunoﬂuorescence in U2OS cells transfected as in a and
treated with CPT (white scale bar represents 10mm; insets represent  3 magniﬁcation). (c) Quantiﬁcation of Ku foci in PCNA-positive cells. U2OS cells
were transfected with the indicated siRNA and pre-treated with dimethylsulfoxide (DMSO) or ATM inhibitor (ATMi) for 1 h, before being CPT treated and
processed for Ku foci detection by immunoﬂuorescence. (d) Graph representing cell viability as determined by clonogenical assays of U2OS cells
transfected with the indicated siRNA and treated for 18 h with CPT in presence of DMSO or DNA-PK inhibitor. T-tests were used to determine
signiﬁcant differences to siCtrl condition. (e) Schematic of CtIP domains indicating the position of the mutated ATM-dependent phosphorylation sites.
(f) Immunoblotting of extracts from U2OS T-REx cells stably transfected with control or siRNA-resistant wild-type (WT) or S-A phosphomutant HA-CtIP
expressing plasmids and transfected with the indicated siRNA. (g) Quantiﬁcation of Ku foci in replicating U2OS T-REx cells complemented with HA-CtIP
(as in f) and CPT treated. Error bars on ﬁgures correspond to s.d.’s. Signiﬁcant differences between speciﬁed pairs of conditions, as judged by t-test, are
highlighted by stars (*Po0.05; **Po0.01; ***Po0.0005). NS, non-signiﬁcant difference.
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addition of ATM inhibitor did not further increase the number of
Ku foci under conditions of CtIP depletion (Fig. 2c), our data
strongly suggested that in this regard, ATM and CtIP function in
the same pathway. These ﬁndings thus suggested that ATM
prevents Ku accumulation on seDSBs by stimulating CtIP
activity, likely through direct CtIP phosphorylation. To test
this, we established a complementation system to express in
CtIP-depleted cells, siRNA-resistant wild-type or mutated CtIP,
the latter bearing Ser to Ala mutations in three of its main
ATM-mediated phosphorylation sites (S664, S679 and S745
(refs 32,33); Fig. 2e,f). In accord with ATM-mediated CtIP
phosphorylation being essential to antagonize Ku accumulation
on seDSBs, unlike wild-type CtIP, the phosphorylation site
(S-4A) mutant CtIP was unable to counteract Ku focus
formation in response to CPT (Fig. 2g). These data
thereby supported a model in which ATM-mediated CtIP
phosphorylation serves to positively regulate the ability of CtIP
to prevent Ku from remaining at seDSBs.
MRE11 nuclease mediates CtIP function in antagonizing Ku.
CtIP has been proposed to function together with the
MRE11–RAD50–NBS1 complex to promote MRE11 nuclease
activity34,35. We therefore tested the role of MRE11 nuclease
activity in counteracting Ku accumulation on seDSBs via
replacing endogenous MRE11 by the H129N mutant, which is
inactivated for both endo- and exonuclease activities36, or by the
wild-type MRE11 protein as a control (Fig. 3a,b). In contrast to
the wild-type protein, expression of nuclease-inactive MRE11 led
to a defect of DNA resection, similar to that caused by CtIP
depletion (Fig. 3c), and also to a strong accumulation of Ku foci
after CPT treatment (Fig. 3d,e). Importantly, CPT-induced
KAP-1 phosphorylation on S824, which is ATM-dependent
(Supplementary Fig. 3a), was essentially the same in wild-type
versus H129N MRE11 expressing cells (Supplementary Fig. 3b),
indicating that ATM activation is not affected by the H129N
mutation. These data thus demonstrated that MRE11 nuclease
activity is critical to restrain Ku from accumulating at seDSBs
generated by CPT and conﬁrmed that it is not required for ATM
activation36. Furthermore, we found that MRE11 nuclease activity
functions in the same pathway as CtIP, since depleting CtIP in
cells expressing MRE11 H129N did not further increase the
number of Ku foci detected on CPT treatment (Fig. 3f).
To address the respective contributions of MRE11 exo- and
endonuclease activities in counteracting Ku accumulation at
seDSBs, and since the scMRE11 H59S mutant is selectively deﬁcient
in exonuclease activity16, we mutated His63, the corresponding
residue in human MRE11 to Ser or Asn, and replaced endogenous
MRE11 by these mutants or wild-type MRE11 protein (Fig. 3g,h).
Through biochemical assays, we found that MRE11 H63N was
devoid of 30–50 exonuclease activity (Fig. 3i–k), while still being able
to associate with RAD50 (Fig. 3l). By contrast, H63S mutant
MRE11 behaved essentially as the wild-type protein in exonuclease
and RAD50-binding assays. Signiﬁcantly, in cells expressing H63N,
Ku foci accumulated on CPT treatment, to about half the level
observed with the nuclease-inactive H129N mutant (Fig. 3m; by
contrast, H63S MRE11 nearly fully complemented the effect on Ku
focus appearance caused by depleting endogenous MRE11). These
data therefore supported a model in which MRE11 30–50
exonuclease activity helps to antagonize Ku at about 40% of
seDSBs, and also highlighted the existence of another mechanism
operating to counteract Ku and in a manner epistatic with MRE11
endonuclease activity.
Mre11 and CtIP nuclease activities cooperate to counteract Ku.
It has been recently reported that in addition to its role in
stimulating MRE11 nuclease activity, human CtIP also has
intrinsic 50-ﬂap endonuclease activity, similar to that described
for scSae2, despite having a different substrate preference24,25,37.
To test a potential function of this activity in antagonizing
CPT-induced Ku foci, we replaced endogenous CtIP by the
N289A H290A (NAHA) mutant, which has been shown to be
selectively inactivated for its ﬂap endonuclease activity
(Fig. 4a,b)24. In contrast to wild-type CtIP, the NAHA mutant
exhibited a partial but signiﬁcant defect in counteracting Ku
accumulation at seDSBs (Fig. 4c). To test if this activity was
working in parallel with MRE11 exonuclease activity, we replaced
endogenous MRE11 and CtIP by wild-type proteins or H63N
MRE11 together with NAHA CtIP (Fig. 4d). If MRE11 and CtIP
activities act in two parallel pathways, an additive effect on Ku
persistence should be observed. However, under these conditions,
we observed that the number of Ku foci on CPT treatment was
essentially equivalent between cells expressing simultaneously
H63N MRE11 and NAHA CtIP proteins (Fig. 4e) and cells
expressing these proteins individually (Figs 3g and 4c; also
represented in grey in the most right-hand part of Fig. 4e).
We therefore concluded that MRE11 exonuclease and CtIP
ﬂap endonuclease activities are epistatic and work together to
antagonizing Ku accumulation at seDSBs. Our data also indicated
that this mechanism operates at B40% of seDSBs (Fig. 4e),
therefore providing further evidence for an additional mechanism
downstream of MRE11 endonuclease activity and in parallel with
MRE11 exonuclease and CtIP endonuclease activities.
Ku at seDSBs impairs RAD51 loading but not DNA resection.
To test the importance of antagonizing Ku at seDSBs for the
process of HR, we used MRE11 H63N to induce Ku persistence
on a subset of seDSBs. When endogenous MRE11 was replaced
by the 30–50 exonuclease-inactive H63N mutant DNA resection
was essentially unaffected (Fig. 5a), in agreement with the idea
that MRE11 exonuclease activity has a minor contribution to
resection, probably due to its activity being initiated from a nick
close to the DNA end17. Importantly, this result also indicated
that DNA resection and RPA loading can progress in the
presence of Ku. Supporting this idea, we could detect
accumulation of Ku80 at 36.5% of RPA70 foci in cells
expressing H63N MRE11 (s.d.±2.1, n¼ 3; Fig. 5b). However,
when RAD51 foci were visualized by immunoﬂuorescence
microscopy in the same cells, a clear defect in focus formation
was observed in cells expressing H63N MRE11 as compared with
cells expressing wild-type MRE11 (Fig. 5c,d). Collectively, these
data indicated that DNA resection and RPA recruitment can
tolerate Ku persistence at DNA ends, and suggest that effective
replacement of RPA by RAD51 requires Ku being cleared away
from the DNA end (Fig. 5e).
Discussion
It has long been clear that after DSB repair, Ku might become
trapped on DNA, thereby interfering with DNA transactions such
as transcription or nucleotide excision repair38,39. It was recently
found that to circumvent such issues, Ku trapped on DNA after
DNA repair is removed in a neddylation-dependent process that
promotes its ubiquitylation, chromatin extraction and probably
proteasome-mediated degradation40,41. Ku can also pose another
problem when loaded on some DNA ends: while NHEJ-mediated
repair is appropriate when two DNA ends are present, it is a
dead-end if it occurs on a seDSB generated by the collision of
replication forks with a DNA lesion. In such circumstances,
Ku could inhibit HR by blocking resection-associated exonuclease
activities, and/or promote aberrant ligation of two seDSBs,
leading to chromosomal rearrangements42.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12889 ARTICLE
NATURE COMMUNICATIONS | 7:12889 | DOI: 10.1038/ncomms12889 | www.nature.com/naturecommunications 5
180
100
55
MW
(kDa)
100
40
15
f
+ siMRE11
n ≥ 4
0
50
100
150
200
Ku
 fo
cu
s 
nu
m
be
r p
er
 c
el
l
CPT:
siCtrl siCtIP siCtrl siCtIP
MRE11-WT
NT 60′ NT 60′ NT 60′ NT 60′ NT 60′ NT 60′
siCtrl siCtIP
MRE11-H129N
NSNS
********
***
***
1 708
Nuclease domain
H63 302
407
Capping DNA
binding
GAR DNA
binding
402 421 556 600 643
692
H129
a
MRE11
Ku70
siRNA: siCtrl siMRE11 
HA-MRE11: – – WT H129N
b
e
HA-MRE11:
n = 3
0
50
100
150
200
Ku
 fo
cu
s 
nu
m
be
r p
er
 c
el
l
NT 60′ NT 60′
WT H129N
siMRE11
CPT:
**
Ku80
PCNA
siMRE11
MRE11 WT MRE11 H129N
NT CPT NT CPT
d
c
DNA content
100
50
0
%
 o
f m
ax
.
100
50
0
%
 o
f m
ax
.
NT
CPT
siRNA:
Plasmid:
RPA+
γH2AX+
siCtrl
42.1
33.1
40.1
3.97
1.89
1.48
1.37
2.66
1 2 1 2
siCtrl siMRE11
1 2 1 2 1 2
4.32
1.15
41.3
25.5
10.2
1.11
7.75
0.53
48.1
28.3
47.5
2.41
siCtIP
– Ctrl H129NMRE11-WT–
m
HA-MRE11:
siMRE11
n ≥ 5
0
50
100
150
200
Ku
 fo
cu
s 
nu
m
be
r p
er
 c
el
l
CPT:
WT H129N
NT 60′ NT 60′ NT 60′ NT 60′
H63S H63N
*******
**
h
MRE11
H2AX
–
β-ACTIN
siCtrl siMRE11
– WT H63N
siRNA:
HA-MRE11: H63S
*
5′ 3′
*3′ 5′
60 bpi
HA-MRE11:
IP HA
–
H129N H63SWT H63N
j
60 bp
50 bp
25 bp
k
l IP HA
HA-MRE11: – H129N H63NWT
RAD50
MRE11
IgG (HC)
H63S
NS
%
 M
RE
11
 W
T 
ac
tiv
ity
0
50
100
150
HA-MRE11:
n = 2
100
MW
(kDa)
70
MW
(kDa)
hMRE11 54 FILLGGDLFHENKPSRKTL 76
scMRE11 50 MVVQSGDLFHVNKPSKKSL 72
.. ***** ****.*.*
Ctrl WT H129N H63S H63N
g
Figure 3 | MRE11 nuclease activities control Ku accumulation at seDSB. (a) Schematic of MRE11 domains with the position of MRE11 H129 and
H63 residues. (b) Immunoblotting of extracts from U2OS T-REx cells stably transfected with control or siRNA-resistant wild-type (WT) or H129N
HA-MRE11-expressing plasmids and transfected with the indicated siRNA. (c) U2OS or U2OS T-REx cells complemented with MRE11 as in b were
transfected with the indicated siRNA, treated with CPT and processed for analysis of DNA resection as monitored by measuring RPA32 association with
chromatin using a ﬂow cytometry assay30. (d,e) Representative micrographs (d) and quantiﬁcation (e) of Ku foci in replicating U2OS T-REx cells
complemented with MRE11 as in b and treated or not with CPT before being processed for immunoﬂuorescence. Replicating cells were identiﬁed using
proliferating cell nuclear antigen (PCNA) staining. (f) Quantiﬁcation of Ku foci in replicating cells. U2OS T-REx cells stably transfected with control or
siRNA-resistant WT or H129N HA-MRE11-expressing plasmids were transfected with the indicated siRNA and Ku foci were quantiﬁed in PCNA-positive
cells. (g) Alignment of scSae2 H59 with human MRE11 H63 revealing that amino acid H59 is conserved in humans and corresponds to H63.
(h) Immunoblotting of extracts from U2OS T-REx cells stably transfected with control or siRNA-resistant WT, H63S or H63N HA-MRE11-expressing
plasmids, and transfected with the indicated siRNA. (i) 50 radio-labelled double-stranded DNA substrate used for in vitro nuclease assays. (j) Analysis by
denaturating PAGE of the exonuclease activity of WT and mutants MRE11 on the probe depicted in i. (k) Quantiﬁcation of nuclease activity in each
condition relative to the MRE11 WTcondition. (l) Immunoblotting of bead-associated complexes used for in vitro nuclease assays. (m) Quantiﬁcation of Ku
foci in replicating U2OS T-REx cells complemented by WT or mutant HA-MRE11 as in f and treated with CPT. Error bars are s.d. Signiﬁcant differences
between speciﬁed pairs of conditions, as judged by t-test, are highlighted by stars (**Po0.01; ***Po0.0005; ****Po0.0001). NS, non-signiﬁcant difference.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12889
6 NATURE COMMUNICATIONS | 7:12889 |DOI: 10.1038/ncomms12889 | www.nature.com/naturecommunications
While the high abundance of Ku and its strong afﬁnity for
DNA ends suggested that it could probably load on any DSB,
including a seDSB, this idea is still debated. Here by showing that
RPA32 phosphorylation on S4/S8 on CPT treatment depends on
the ability of Ku to bind DNA and on DNA-PK kinase activity,
we establish that Ku is initially loaded on seDSBs. In accord with
this, a recent study based on puriﬁcation of proteins associated
with nascent DNA established that Ku associates with replication
sites shortly after CPT treatment of human cells43. Collectively,
these ﬁndings have several implications. First, they show that
Ku indeed recognizes seDSBs induced by CPT. Second, since
RPA loading requires ssDNA formation, and because RPA
phosphorylation by DNA-PK necessitates the two factors being
close together, resection must actually be initiated in the context
of Ku bound to the DNA end. This conclusion is in line with our
ﬁnding that resection can be essentially normal despite a partial
defect in Ku removal caused by an exonuclease-inactive MRE11
mutant (Figs 3m and 5a) and our previous demonstration that Ku
and MRE11–RAD50–NBS1 can coexist at the same DNA end23.
Collectively, the available data support the existence of a
‘bi-directional resection’ mode in human cells that leads to an
intermediate structure depicted in the model presented in Fig. 5e
in which resection and RPA-bound ssDNA coexist with Ku that is
still bound to the adjacent DSB DNA end. Such a model would
explain how we found Ku and RPA to co-localize at CPT-induced
seDSBs in cells in which MRE11 exonuclease activity was
inactivated (Fig. 5b).
Our work provides evidence for the binding of Ku to seDSBs and
highlights the importance of deciphering mechanisms regulating its
residence at such structures. Here by using a method to monitor Ku
DSB loading23, we conﬁrmed that Ku is prevented from remaining
at seDSBs in human cells by the DNA-nicking endonuclease
activity of the CtIP–MRE11 complex (Fig. 3f). Furthermore,
through quantitative evaluations, we established that MRE11
exonuclease activity limits Ku persistence at a subset of seDSBs
(Fig. 3m). We thus propose a model wherein MRE11 exonuclease
activity functions to process the DNA ﬂanking Ku at these seDSBs
(Fig. 5e). Since we also obtained evidence that CtIP 50-ﬂap
endonuclease activity is epistatic to MRE11 exonuclease activity
(Fig. 4e), we propose that MRE11 exonuclease activity primes the
DNA-ﬂanking Ku for cleavage by CtIP ﬂap endonuclease activity,
by generating a DNA structure that CtIP has been shown to cleave
in vitro24,25 (Fig. 5e). Such a mechanism would thereby promote
efﬁcient repair by HR through minimizing the size of the double-
stranded DNA region produced by CtIP endonuclease activity and
optimizing the extent of ssDNA available for strand invasion19.
Our work therefore supports strong coordination between MRE11
endo- and exonuclease and CtIP endonuclease activities, a
mechanism that is likely to be conserved in other organisms,
since scSae2, the CtIP homologue in S. cerevisiae, has also been
reported to display structure-speciﬁc endonuclease activity24,37.
Contrasting with previous models wherein MRE11 exonuclease
activity somehow pushes Ku away and off DNA ends44, our data
support a model in which Ku afﬁnity for DNA ends prevents its
simple release through displacement from a subset of DNA ends
and instead requires the elimination of a fragment of double-
stranded DNA carrying Ku. The generation and fate of such DNA
fragments clearly deserve further investigations.
Our work has also highlighted how ATM kinase activity is
critical in limiting Ku residence at seDSBs through the
phosphorylation of CtIP. How CtIP phosphorylation regulates
CtIP activity is still unclear but our data are in agreement with
recent work showing that CtIP endonuclease activity depends on
ATM-dependent CtIP phosphorylation24. The function of ATM
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in promoting HR-dependent DSB repair was already well
documented45–48, despite the fact that in mouse cells, the
impact of ATM inhibition on HR repair is not equivalent to
loss of ATM protein49,50. Our work thereby further highlights
how targeting ATM kinase could be used to increase the
efﬁciency of CPT derivatives in anticancer treatments through
blocking HR-dependent DNA repair processes.
While Ku binding to DNA DSBs represents the ﬁrst step of
NHEJ, our data indicate that it can also be regarded as the ﬁrst
step in HR, with Ku binding protecting DNA ends from
unregulated processing and helping to create a situation in which
signals are integrated into a ‘decision’ whether the break should
be channelled into NHEJ or HR. Supporting this model, previous
works in yeast have shown that Ku has a function at seDSBs, and
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more generally at DSBs, to regulate the timing of DNA-end
processing through blocking access of certain factors to DNA
ends13,51–54. It seems likely that multiple signals promoting HR,
such as cyclin-dependent kinase-mediated phosphorylations, the
presence or absence of cohesin, chromatin state and nuclear
architecture might depend on and/or cooperate with Ku to
regulate the balance between NHEJ and HR8,10,55,56. While
DNA resection can be initiated and performed in the presence
of Ku, our ﬁndings indicate that the replacement of RPA by
RAD51 is impaired by the presence of Ku at the DNA end
(Fig. 5c). This suggests that RPA-RAD51 exchange on ssDNA
is coupled to the removal of Ku and/or the Ku-associated
double-stranded DNA fragment from DNA ends. The
mechanism for such coupling clearly deserves exploration
through further studies.
Our work also opens new directions for research by providing
evidence for an as-yet uncharacterized mechanism working
downstream of MRE11 endonuclease activity—and in parallel
to MRE11 exonuclease and CtIP ﬂap-endonuclease activities—to
mediate Ku release from more than half of seDSBs (Fig. 4e).
Several nuclease activities might substitute for MRE11
exonuclease and/or CtIP endonuclease functions. Alternatively,
in some cases, Ku might be modiﬁed to loosen its afﬁnity for
DNA ends, perhaps as mimicked by separation-of-function
mutants in yeast51 or degraded at seDSB sites by mechanisms
related to those shown to mediate Ku release from DNA after
DSB repair is complete40,41. In this regard, we note that the
RNF138 E3 ubiquitin ligase has recently been shown to promote
HR and to function in the same pathway as MRE11 to promote
Ku release57,58.
Finally, we suggest that coordination of MRE11 and CtIP
nuclease activities is likely to operate at various DNA lesions,
including ‘masked’ breaks generated by topoisomerase II
inhibition, DNA breaks generated during meiosis by Spo11
nuclease and complex DSBs generated by heavy-particle irradia-
tion. In all these cases, DNA end binding by the Ku protein is
prevented by bulkiness or complexity at DNA ends, and NHEJ
might be unable to proceed. Attacking the DNA ends ‘from the
ﬂank’ through MRE11 endonuclease activity may have evolved to
deal with these types of DNA lesions, while the ability to cleave
the second DNA strand when displacement of the end-blocking
lesion is not possible might constitute a second system to free the
end for productive repair. This second mechanism might be
especially relevant in the repair of complex DNA DSBs that are
resected independently of cell cycle phase59–61.
Methods
Cell culture. U2OS and U2OS T-REx (from American Type Culture Collection
and Thermo Fisher Scientiﬁc, respectively) were grown in a 5% CO2 humidiﬁed
incubator at 37 C in Dulbecco’s modiﬁed Eagle’s medium supplemented with 10%
fetal bovine serum, 2mM L-glutamine, 100Uml 1 penicillin and 100 mgml 1
streptomycin. Cells were routinely tested for mycoplasma contamination by DNA
staining and microscopy, and mycoplasma-free cells were used in all experiments.
siRNA transfection. A list of siRNAs used in this work is provided in
Supplementary Table 1. siRNA transfections were performed with Lipofectamine
RNAiMAX (Thermo Fisher Scientiﬁc) using the manufacturer’s instructions. Final
concentrations of siRNAs were 50 nM in each experiment. Where two siRNAs were
used simultaneously, each was used at a concentration of 25 nM. For most
experiments, two rounds of transfection were performed at 24 h intervals, and
experiments were carried out 48 h after the second transfection. For experiments in
GFP-FLAG-Ku70-expressing cells, previously published conditions were used23.
Plasmids. All plasmids generated for complementation experiments are deposited
on the Addgene plasmid repository together with fully annotated maps and
sequences. Details about plasmid construction are provided in Supplementary
Methods together with a table with the oligonucleotides used (Supplementary
Table 2).
Plasmid transfection and stable cell generation. Plasmid transfections were
carried out with Lipofectamine 2000 (Thermo Fisher Scientiﬁc) according to the
manufacturer’s instructions. For stable transfections, 5 mg of DNA and 10ml of
Lipofectamine 2000 were used to transfect 106 U2OS T-REx cells seeded the day
before in a 60mm dish. The day after transfection, various cell dilutions were
seeded into 140mm dishes and puromycin was added at 0.25 mgml 1 for
selection. Two to three weeks afterwards, individual clones were isolated and
screened.
DNA damage and drug treatments. DNA-PK inhibitor (NU7441) and ATM
inhibitor (KU-55933), both from Tocris Bioscience, were used at 3 and 10 mM,
respectively, with a pre-incubation period of 1 h. Aphidicolin (Sigma-Aldrich) was
used at 10 mM with a pre-incubation period of 90min. For inducing protein
expression with pICE, doxycycline (Doxy, Clontech) was added at 2 mgml 1
24 h before treatment, and drug treatments were performed in presence of Doxy.
CPT (Sigma-Aldrich) was used at 1 mM for 1 h. Ionizing radiation treatments
correspond to a 10Gy X-ray irradiation, using calibrated irradiators (RX-650;
Faxitron) ﬁtted with a 0.5mm aluminum ﬁlter for soft X-rays, followed by a 5min
post-incubation.
Antibodies. A list of all primary antibodies used in this work together with
working conditions is provided in Supplementary Table 3.
Immunoblotting. For immunoblotting, whole-cell extracts were prepared by
scraping cells in SDS-lysis buffer (SLB; 4% SDS, 20% glycerol and 120mM
Tris-HCl (pH 6.8)), boiling 5min at 95 C and 10 strokes through a 25G needle.
Lysates were diluted to 5 mgml 1 in SLB. For loading, an equal volume of a
solution of 0.01% bromophenol blue and 200mM dithiothreitol was added to the
extracts which were boiled for 5min at 95 C. A unit of 40–50 mg of denatured
proteins were loaded for each condition and separated on SDS pre-cast gradient
4–12% polyacrylamide TGX gels (Biorad) and transferred on to nitrocellulose
membrane (Protran, Whatman). Ponceau S staining was used to conﬁrm
homogeneous loading and the membrane was cut into horizontal strips that were
subsequently probed with the appropriate primary antibody and appropriate
donkey secondary antibodies coupled to IRDye 800CW (LI-COR Biosciences).
An infrared imager was used for detection (Odyssey, LI-COR Biosciences). Digital
data were processed using Fiji62 and cropped using Photoshop CS6 (Adobe).
Uncropped scans of the most important blots are provided in Supplementary
Fig. 4.
Immunoﬂuorescence. Cells were seeded on B160mm thick coverslips
(VWR International) 24 h before experiments. After treatments, cells were
pre-extracted by two incubation of 3min at room temperature with CSK buffer
(10mM PIPES (pH 7), 100mM NaCl, 300mM sucrose, 3mM MgCl2 and 0.7%
Triton X-100) containing 0.3mgml 1 RNase A (CSKþR), except for RAD51 foci
for which pre-extractions were performed once with CSK on ice for 5min. After
pre-extraction, cells were washed with PBS and ﬁxed 15–20min with 2% paraf-
ormaldehyde in PBS before being washed three times with PBS. Before staining,
cells were permeabilized 5min with PBS/0.2% Triton X-100, washed with PBS and
blocked with PBS/0.1% Tween-20 (PBS-T) containing 5% bovine serum albumin
(BSA). Coverslips were incubated 75min with primary antibodies in PBS-T/5%
BSA, then washed with PBS-T and incubated 45min with appropriate goat sec-
ondary antibodies coupled to AlexaFluor 488 or 594 ﬂuorophores (Thermo Fisher
Scientiﬁc for anti-mouse and rabbit and Abcam for anti-rat) in PBS-T/5% BSA.
Note that for RAD51 staining, the primary antibodies were incubated sequentially.
After washes in PBS-T and PBS, coverslips were incubated 15–30min with
1 mgml 1 40 ,6-diamidino-2-phenylindole (DAPI) in PBS. After washes in PBS,
coverslips were dipped in water and mounted on glass slides using VectaShield
(Vector Labs) mounting medium.
High-resolution imaging using deconvolution. High-resolution pictures were
acquired by imaging z-stacks containing the whole-cell nucleus with a wide-ﬁeld
Deltavision PersonalDV microscope (Applied Precision, 1,024 1,024 CoolSNAP
HQ or HQ2 camera, z-stack of 0.2 mm interval) equipped with a  100
UPlanSApo/1.40 oil objective (Olympus). Deconvolutions were then performed
with SoftWoRx (Applied Precision) in conservative mode. On all pictures in the
manuscript, the white scale bars correspond to 10 mm. For RPA70 and P-RPAS4/S8
staining, micrographs correspond to the projection of the maximum intensity of
two adjacent slices, while for other staining they correspond to a single slice.
Quantiﬁcation of focus number per cell and focus intensity. For Ku,
P-RPAS4/S8, RPA70 and RAD51 foci quantiﬁcation, cells were pre-extracted and
processed for immunoﬂuorescence. Deconvoluted pictures of 410 cells were
acquired for each condition and submitted to automated focus detection using the
3D Objects Counter macro of Fiji, with 10 and 300 pixels the minimum and
maximum size of foci, respectively, and with a threshold adjusted in each
experiment using a positive control62,63. To identify cells in S-phase, cells were
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co-stained for proliferating cell nuclear antigen, a protein that accumulates at
chromatin in S-phase and persists after CSKþR extraction (Supplementary Fig. 1).
For RAD51 and Ku80 foci quantiﬁcations, the average number of foci in untreated
cells was subtracted from the average number of foci in treated conditions, to
concentrate our analysis on the foci induced by CPT. For quantiﬁcation of
P-RPAS4/S8 focus intensity, automated focus detection was used as previously
described to measure max intensity of individual foci. To compute the distribution
of focus intensity, in each experiment the intensity of individual foci was
normalized to the average max intensity, and the frequency distribution was
plotted as per cent of the total number of foci. The graphs were then generated
out of four independent experiments processed in a similar way.
Cell survival by clonogenical assays. Cell survival were performed as follows23.
Brieﬂy, after transfection with siRNA, cells were seeded at low density the day
before treatment, pre-incubated with DNA-PK inhibitor or dimethylsulfoxide for
1 h and treated for 18 h with CPT in presence of inhibitor or dimethylsulfoxide
before being washed three times. After 10–15 days, cells were stained with crystal
violet and the colonies counted. Data were normalized to the untreated conditions
to take into account variations in plating efﬁciency.
HA-MRE11 immunoprecipitation. After siRNA-mediated depletion of
endogenous MRE11, U2OS T-REx cells stably transfected with control plasmid or
plasmid expressing wild-type, H129N, H63S or H63N HA-MRE11 were induced
for 24 h with Doxy and cell pellets were collected by scraping cells in cold PBS. For
each immunoprecipitation (IP), we used 200 mg of proteins from the supernatant
obtained after centrifugation 5min at 21,890 g at 4 C of cell pellets
resuspended and incubated 30min at 4 C in IP lysis buffer (20mM Tris-HCl
(pH 7.8), 150mM NaCl, 1mM EDTA, 0.5% NP-40 and 0.2mgml 1 RNase A).
The volume of supernatant used was adjusted to 300 ml using IP lysis buffer, and
500ml IP dilution buffer (20mM Tris-HCl (pH 7.8), 150mM NaCl, 1mM EDTA
and 0.05% NP-40) was added to bring NP-40 concentration under 0.2%. Diluted
extracts were incubated 4 h at 4 C with 50ml of protein G-coupled magnetic beads
(Dynabeads M-280; Thermo Fisher Scientiﬁc) pre-loaded with 7 mg anti-HA
antibody (HA-7; Sigma-Aldrich). The beads were then washed three times with IP
wash buffer (20mM Tris-HCl (pH 7.8), 500mM NaCl, 1mM EDTA and 0.05%
NP-40) and once with IP dilution buffer. The beads were resuspend in 50 ml
dilution buffer, and 5 ml was used for analysing by immunoblotting the amount of
HA-MRE11 in each conditions together with the ability of the various MRE11
mutants to interact with RAD50. The rest was used for in vitro exonuclease assays.
All buffers were supplemented with protease and phosphatase inhibitors
(HALT cocktail, Pierce).
On beads MRE11 exonuclease assay. HA-MRE11 was immunoprecipitated as
described above. Beads were then washed once with IP dilution buffer without
protease and phosphatase inhibitors and once with exonuclease buffer (25mM
MOPS KCl (pH 7), 10mM KCl, 5mM MnCl2, 0.05% Tween-20 and 1mM
dithiothreitol). Beads were then resuspended in 50 ml exonuclease buffer containing
1mM ATP and 0.01 pmol 60-nucleotide-long double-stranded blunt-ended
DNA substrate radioactively labelled at both 50-ends, generated by annealing
oligonucleotides ExoProbe-S and ExoProbe-AS previously labelled with g32P-ATP
by the T4 polynucleotide kinase according to the manufacturer’s instructions
(Thermo Fisher Scientiﬁc). Beads were incubated 3 h at 37 C with intermittent
shaking at 1,400 r.p.m. for 15 s every 2min (ThermoMixer, Eppendorf). A volume
of 50 ml of 2 proteinase K buffer (100mM Tris-HCl (pH 7.8), 1% SDS and 2mM
CaCl2) was added to the beads, which were then incubated at 95 C for 4min.
A volume of 1 ml of proteinase K (Euromedex) at 20mgml 1 was added to the
beads that were incubated 30min at 50 C with intermittent shaking as described
above. The beads were incubated at 95 C for 4min and the supernatant was
recovered by magnetic separation. A volume of 50 ml of Tris-EDTA was added to
the supernatant and DNA was isolated by phenol-chloroform extraction. Ethanol
precipitation was then used to isolate DNA from the aqueous phase using
20mgml 1 yeast tRNA, 0.3M sodium acetate and 10mM MgCl2 for maximum
precipitation efﬁciency. Dry DNA was then resuspended in Ficoll loading buffer
(1 TBE, 6% Ficoll-400 and 0.02% bromophenol blue), boiled 95 C for 3min and
separated on a 10% polyacrylamide 7M urea 1 TBE gel. The gel was then
exposed on a Storage Phosphor Screen (GE Healthcare) that was scanned on a
Storm 840 (GE Healthcare). Digital data were processed using Fiji62 and cropped
using Photoshop CS6 (Adobe). Quantiﬁcation of the percentage of exonucleolytic
products was performed by measuring with Fiji62 the integrated signal intensity
corresponding to the degradation products over the total integrated intensity in the
corresponding lane.
Flow cytometry analysis of RPA recruitment to chromatin. Analysis of RPA32
association to chromatin was as follows30. Brieﬂy, at the end of treatment, cells
were collected by trypsination, washed with PBS and pre-extracted by a 10min
incubation on ice in PBS 0.2% Triton X-100 to remove soluble RPA32. Then cells
were washed in PBS 1% BSA and ﬁxed for 15min with 2% paraformaldehyde. After
ﬁxation, cells were washed in PBS 1% BSA, incubated 30min at room temperature
in PBS 0.2% Triton X-100, washed in PBS 1% BSA and incubated 1 h at room
temperature in PBS-T 5% BSA containing mouse anti-RPA32 and rabbit anti-
gH2AX antibodies. Cells were then washed in PBS 1% BSA and incubated 30min
at room temperature in PBS-T 5% BSA containing goat anti-mouse and anti-rabbit
secondary antibodies coupled to AlexaFluor 488 and AlexaFluor 647, respectively,
diluted at 1/200. Cells were then washed with PBS 1% BSA and incubated in PBS
containing 0.25mgml 1 RNase A and 2 mgml 1 DAPI. A minimum of 30,000
cells were analysed on a BD LSR II ﬂow cytometer (Becton Dickinson). Data were
analysed and formatted using FlowJo v8.8.7. Black and red numbers on each ﬂow
cytometry proﬁle correspond to the percentage of gH2AX and RPA32 positive
cells, respectively.
Statistical analysis. When statistical analyses were required, an unpaired
two-tailed Student’s t-test was performed using GraphPad Prism 5.0 (GraphPad
Software) between pairs of conditions. Error bars on ﬁgures correspond to s.d.’s.
On all ﬁgures, signiﬁcant differences between speciﬁed pairs of conditions are
highlighted by stars (*Po0.05; **Po0.01; ***Po0.0005; ****Po0.0001). NS stands
for non-signiﬁcant difference.
Data availability. The plasmids generated for this work have been deposited on
the Addgene plasmid repository (Plasmids #82030; #82031; #82032; #82033;
#82034; #82035 and #82036). The authors declare that the data supporting the
ﬁndings of this study are available within the article and its Supplementary
Information ﬁle, and on request.
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